Quinone-masked probes as labeling reagents for cell uptake measurements
US-2015307916-A1 · Oct 29, 2015 · US
US9927430B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9927430-B2 |
| Application number | US-201514608910-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 29, 2015 |
| Priority date | Jan 29, 2014 |
| Publication date | Mar 27, 2018 |
| Grant date | Mar 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are pro-substrates useful in assays of living cells. The pro-substrates can be used to detect the presence or absence of enzymes, such as luciferase, in living cells. The pro-substrates can be coelenterazine derivatives or analogs.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I), or a salt thereof, wherein, R A is selected from the group consisting of —(CR 1 R 2 ) m —N(R 3 )C(O)R 4 , —(CR 5 R 6 ) m —SO 3 R 7 , and —(CR 10 R 11 ) m —CO 2 R 12 , wherein m at each occurrence is independently 2, 3, or 4; R 1 , R 2 , R 3 , R 5 , R 6 , R 7 , R 10 , R 11 , and R 12 at each occurrence are independently hydrogen or C 1 -C 4 alkyl; R 4 is C 1 -C 4 alkyl, C 1 -C 4 alkoxy, carboxy-C 1 -C 4 alkoxy-C 1 -C 4 alkyl, phenyl optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from the group consisting of halogen, C 1 -C 4 alkoxy, and C 1 -C 4 haloakyl, wherein R 41 , R 42 , and R 44 at each occurrence are each independently carboxy-C 1 -C 4 alkyl; R 43 and R 45 are each independently selected from the group consisting of hydrogen, —C(O)alkyl, and x and y are each independently an integer selected from 1 to 20; R B is —(CR 46 R 47 ) t —NR 48 R 49 , wherein t is 1, 2, 3, 4, 5, 6, 7, or 8 R 46 and R 47 at each occurrence are independently hydrogen or C 1 -C 4 alkyl; R 48 and R 49 at each occurrence are independently hydrogen, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, haloalkoxyalkyl, aminoalkyl, alkylaminoalkyl, di(alkyl)aminoalkyl, cyanoalkyl, —(CR 50 R 51 ) z —OC(O)R 52 ; or R 48 and R 49 together with the nitrogen atom to which they are attached form a heterocyclyl, wherein said heterocyclyl is unsubstituted or substituted with 1, 2, 3, 4, 5 or 6 substituents independently selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 alkenyl, C 1 -C 4 alkynyl, —NO 2 , —CN, halogen, oxo, —OR 96 , —OC(O)R 97 , and —C(O)R 116 , wherein R 50 and R 51 at each occurrence are independently hydrogen or C 1 -C 4 alkyl; R 52 , R 96 , R 97 , and R 116 at each occurrence are independently hydrogen, C 1 -C 6 alkyl, or aryl; z is 1, 2, 3, or 4; R C is —(CH) 0-3 -T or C 1-5 alkyl; wherein T is aryl, heteroaryl, or cycloalkyl, wherein said aryl, heteroaryl, and cycloalkyl are each independently unsubstituted or substituted with 1, 2, or 3 substituents independently selected from the group consisting of halogen, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, haloalkoxyalkyl, aminoalkyl, alkylaminoalkyl, di(alkylaminoalkyl), cyanoalkyl, alkoxy, haloalkoxy, cyano, hydroxy, amino, alkylamino, and di(alkyl)amino; R D is hydrogen, C 1 -C 4 alkyl, benzyl, or C 3 -C 6 cycloalkyl; R E is hydrogen, hydroxy, alkoxy, amino, alkylamino, di(alkyl)amino, —OC(O)alkyl, or —OCH 2 OC(O)alkyl; wherein the dash bonds together indicate the presence of an optional 6-membered ring in the compound of formula (I), wherein the optional ring is saturated or unsaturated; and wherein the optional 6-membered ring is absent. 2. The compound of claim 1 , or a salt thereof, wherein R A is —(CR 1 R 2 ) m —N(R 3 )C(O)R 4 , wherein m, R 1 , R 2 , R 3 , and R 4 are as defined in claim 1 . 3. The compound of claim 1 , or a salt thereof, wherein R A is selected from the group consisting of: 4. The compound of claim 1 , or a salt thereof wherein R B is selected from the group consisting of: 5. The compound of claim 1 , or a salt thereof wherein R C is furylmethyl or benzyl, R D is benzyl, or R E is hydrogen. 6. The compound of claim 1 , having formula (I-iv), or a salt thereof, wherein R 200 is aryl or heteroaryl, each optionally substituted with 1, 2, or 3 substituents independently selected from the group consisting of halogen, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, haloalkoxyalkyl, aminoalkyl, cyanoalkyl, alkoxy, haloalkoxy, cyano, hydroxy, and amino; and R A , and R B are as defined in claim 1 . 7. The compound of claim 1 , having formula (I-x), or a salt thereof, wherein s is 1 or 2; R 201 is aryl or heteroaryl, each optionally substituted with 1, 2, or 3 substituents independently selected from the group consisting of halogen, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, haloalkoxyalkyl, aminoalkyl, cyanoalkyl, alkoxy, haloalkoxy, cyano, hydroxy, and amino; and R A is as defined in claim 1 . 8. The compound of claim 2 , having formula (I-xvii), or a salt thereof, wherein q is 1 or 2; s is 1 or 2. 9. The compound of claim 1 , or a salt thereof, selected from the group consisting of: or a salt thereof. 10. The compound of claim 1 , or a salt thereof, wherein R A is wherein R 41 , R 42 , R 43 , R 44 , R 45 , x, and y are as defined in claim 1 ; and R B is 11. A composition comprising a mixture of a compound of formula (I) according to claim 1 , or a salt thereof, and at least one compound of formula (II), wherein R C , R D , and R E in formula (II) are as defined in claim 1 ; and wherein the dash bonds of formula (II) indicates an optional 6-membered ring, which is absent. 12. The composition according to claim 11 , wherein the compound of formula (II) is selected from the group consisting of (II-i), (II-ii), (II-iii), (II-iv), and (II-v), or a combination thereof, 13. A method to detect an interaction between a first protein and a second protein in a sample, the method comprising: (a) contacting a sample with the compound of claim 1 , or a salt thereof, wherein the sample comprises: (i) a first polynucleotide encoding a first fusion protein, wherein the first fusio
Ortho-condensed systems · CPC title
with the first amino acid being acidic · CPC title
with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title
involving luciferase · CPC title
Methods of identifying protein-protein interactions in protein mixtures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.